Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
Nurix Therapeutics, Inc.
Actuate Therapeutics Inc.
Eisai Inc.
M.D. Anderson Cancer Center
University of Maryland, Baltimore
University of Maryland, Baltimore
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fox Chase Cancer Center
Memorial Sloan Kettering Cancer Center
Fox Chase Cancer Center
National Cancer Institute (NCI)
Northwestern University
Swiss Cancer Institute
National Institutes of Health Clinical Center (CC)
NYU Langone Health
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)